For example, treatment of breast tumor cells with rapamycin reduces the phosphorylation of the mTOR targets S6K and 4EBP1 while simultaneously increasing the phosphorylation of AKT and eIF4E. This evidence concerns the gene RPS6KB1 and breast neoplasm.